Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-080946
Filing Date
2019-03-20
Accepted
2019-03-20 17:13:02
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d723059d424b5.htm 424B5 528228
2 GRAPHIC g723059g23a75.jpg GRAPHIC 38472
3 GRAPHIC g723059g38y52.jpg GRAPHIC 143434
4 GRAPHIC g723059g92q50.jpg GRAPHIC 39693
  Complete submission text file 0001193125-19-080946.txt   834515
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-229499 | Film No.: 19695254
SIC: 2834 Pharmaceutical Preparations